Unibest
← Back to patent-cliff list

Josamycin Propionate

Tier C — Watch / trade

Josamycin Propionate

-
Originator
1995
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:50S ribosomal subunit

Indications (approved):Bacterial infection, Inflammatory disease

Regional status

US
-
EU
-
China
Approved
1995-01-01
Japan
-

Synthetic routes & intermediates3 routes

Originator routes × 0Optimised (non-patent) × 3Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OptimisedRoute 1Steps 13 · Total yield /
Josamycin-001582-52-5Josamycin-002—Josamycin-003—Josamycin-004—Josamycin-005—Josamycin-006—Josamycin-0072605-67-6Josamycin-008—Josamycin-00976859-44-4Josamycin-010—Josamycin-01176859-46-6Josamycin-012—Josamycin-01376859-47-7Josamycin-014—Josamycin-01576859-48-8API · Josamycin Propionate
CodeCAS No.Intermediate
Josamycin-001582-52-5(3aR,5S,6S,6aR)-5-[(4R)-2,2-Dimethyl-1,3-dioxolan-4-yl]-2,2-dimethyltetrahydro-2H-furo[2,3-d][1,3]dioxol-6-ol
Josamycin-002-(3aS,5S,6R,6aS)-5-[(4S)-2,2-Dimethyl-1,3-dioxolan-4-yl]-6-methoxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxole
Josamycin-003-1,2-O-Isopropylidene-3-O-methyl-alpha-L-glucofuranose
Josamycin-004-6-O-Benzoyl-1,2-O-isopropylidene-3-O-methyl-alpha-L-glucofuranose
Josamycin-005-6-O-Benzoyl-1,2-O-isopropylidene-3-O-methyl-5-O-[(4-methylphenyl)sulfonyl]-alpha-L-glucofuranose
Josamycin-006-5-Deoxy-1,2-O-isopropylidene-3-O-methyl-alpha-L-xylo-hexofuranose
Josamycin-0072605-67-6(Carbomethoxymethylene)triphenylphosphorane
Josamycin-008-Methyl (2E)-2,3,7-trideoxy-5-O-methyl-D-xylo-oct-2-enonate
Josamycin-00976859-44-4Methyl (2E)-2,3,7-trideoxy-4,6-O-isopropylidene-8-O-(methoxymethyl)-5-O-methyl-D-xylo-oct-2-enonate
Josamycin-010-Methyl (4xi)-2,3,7-trideoxy-4,6-O-isopropylidene-8-O-(methoxymethyl)-5-O-methyl-3-[(methylsulfanyl)(methylsulfinyl)methyl]-D-lyxo-octonate
Josamycin-01176859-46-6(4R,5S)-5-[(1S,2R)-2,4-Dihydroxy-1-methoxybutyl]-4-[(ethylsulfanyl)(methylsulfanyl)methyl]dihydrofuran-2(3H)-one
Josamycin-012-2,3,7-Trideoxy-3-[(ethylsulfanyl)(methylsulfanyl)methyl]-5-O-methyl-D-ido-octofuranose
Josamycin-01376859-47-7Methyl 2,3,7-trideoxy-3-[(ethylsulfanyl)(methylsulfanyl)methyl]-5-O-methyl-D-ido-octofuranoside
Josamycin-014-Methyl 6,8-di-O-benzyl-2,3,7-trideoxy-3-[(ethylsulfanyl)(methylsulfanyl)methyl]-5-O-methyl-D-ido-octofuranoside
Josamycin-01576859-48-8Methyl 6,8-di-O-benzyl-2,3,7-trideoxy-3-formyl-5-O-methyl-D-ido-octofuranoside
OptimisedRoute 2Steps 8 · Total yield /
Josamycin-01576859-48-8Josamycin-01626487-92-3Josamycin-0174091-39-8Josamycin-018—Josamycin-019—Josamycin-020—Josamycin-021—Josamycin-022—Josamycin-023—Josamycin-024—Josamycin-025—API · Josamycin Propionate
CodeCAS No.Intermediate
Josamycin-01576859-48-8Methyl 6,8-di-O-benzyl-2,3,7-trideoxy-3-formyl-5-O-methyl-D-ido-octofuranoside
Josamycin-01626487-92-33-(Triphenylphosphoranylidene)butan-2-one
Josamycin-0174091-39-81-Acetyl-1-chloroethane
Josamycin-018-Methyl 6,8-di-O-benzyl-2,3,7-trideoxy-5-O-methyl-3-[(1Z)-2-methyl-3-oxobut-1-en-1-yl]-D-ido-octofuranoside
Josamycin-019-Methyl 2,3,7-trideoxy-5-O-methyl-3-(2-methyl-3-oxobutyl)-D-ido-octofuranoside
Josamycin-020-Methyl 2,3,7-trideoxy-5-O-methyl-3-(2-methyl-3-oxobutyl)-D-ido-octofuranosiduronic acid
Josamycin-021-Dimethyl 2,3,7-trideoxy-5-O-methyl-3-[(2R)-2-methyl-3-oxobutyl]-D-ido-octofuranosiduronate
Josamycin-022-(2E)-5-Hydroxyhex-2-enal
Josamycin-023-Dimethyl 2,3,7-trideoxy-3-[(2R,4E,6E,9R)-9-hydroxy-2-methyl-3-oxodeca-4,6-dien-1-yl]-5-O-methyl-D-ido-octofuranosiduronate
Josamycin-024-Methyl 2,3,7-trideoxy-3-[(2R,4E,6E,9R)-3,9-dihydroxy-2-methyldeca-4,6-dien-1-yl]-5-O-methyl-D-ido-octofuranosiduronic acid
Josamycin-025-Methyl S-phenyl 2,3,7-trideoxy-3-[(2R,4E,6E,9R)-3,9-dihydroxy-2-methyldeca-4,6-dien-1-yl]-5-O-methyl-8-thio-D-ido-octofuranosiduronate
OptimisedRoute 3Steps 5 · Total yield /
Josamycin-025—Josamycin-02676859-54-6Josamycin-027—Josamycin-028—Josamycin-029—Josamycin-030—API · Josamycin Propionate
CodeCAS No.Intermediate
Josamycin-025-Methyl S-phenyl 2,3,7-trideoxy-3-[(2R,4E,6E,9R)-3,9-dihydroxy-2-methyldeca-4,6-dien-1-yl]-5-O-methyl-8-thio-D-ido-octofuranosiduronate
Josamycin-02676859-54-6(3aR,5R,7E,9E,12R,16R,17S,17aS)-6,16-Dihydroxy-2,17-dimethoxy-5,12-dimethyl-2,3,3a,4,5,6,11,12,15,16,17,17a-dodecahydro-14H-furo[2,3-f]oxacyclohexadecin-14-one
Josamycin-027-(3aR,5R,7E,9E,12R,16R,17S,17aS)-16-Hydroxy-2,17-dimethoxy-5,12-dimethyl-3,3a,11,12,15,16,17,17a-octahydro-4H-furo[2,3-f]oxacyclohexadecine-6,14(2H,5H)-dione
Josamycin-028-(3aR,5R,7E,9E,12R,16R,17S,17aS)-2,17-Dimethoxy-5,12-dimethyl-6,14-dioxo-2,3,3a,5,6,11,12,14,15,16,17,17a-dodecahydro-4H-furo[2,3-f]oxacyclohexadecin-16-yl acetate
Josamycin-029-(3aR,5R,7E,9E,12R,16R,17S,17aS)-2-Hydroxy-17-methoxy-5,12-dimethyl-6,14-dioxo-2,3,3a,5,6,11,12,14,15,16,17,17a-dodecahydro-4H-furo[2,3-f]oxacyclohexadecin-16-yl acetate
Josamycin-030-(4R,5R,6S,7R,9R,11E,13E,16R)-7-(1,3-Dioxolan-2-ylmethyl)-6-hydroxy-5-methoxy-9,16-dimethyl-2,10-dioxooxacyclohexadeca-11,13-dien-4-yl acetate

Frequently asked questions

What are the approved indications of Josamycin Propionate?

Approved indications include: Bacterial infection, Inflammatory disease.

When does the Josamycin Propionate patent expire?

No public expiry year is available for Josamycin Propionate yet; this page updates once verified.

How many synthesis routes are recorded for Josamycin Propionate?

3 synthesis routes are recorded; the shortest is 5 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Josamycin Propionate intermediates?

All intermediates in Josamycin Propionate routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Josamycin Propionate intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-04